Beigene (BGNE)

Trade BGNE now with
12/20/2021 6:32:02 AM Novartis Inks Option, Collaboration And License Agreement With BeiGene For Ociperlimab
12/13/2021 11:10:05 PM Nanjing Leads Biolabs And BeiGene Announce Worldwide License And Collaboration Agreement For LBL-007 Anti-LAG-3 Antibody
12/3/2021 12:40:32 AM BeiGene, EUSA Pharma Unveil China's NMPA Approval Of SYLVANT For Idiopathic Multicentric Castleman Disease
11/30/2021 9:07:49 AM BeiGene Announces Pricing Of US$3.5 Bln IPO On STAR Market Of Shanghai Stock Exchange In China
8/18/2021 4:19:16 AM BeiGene : Swissmedic Accepts Marketing Application For BRUKINSA In Waldenström's Macroglobulinaemia
9/21/2020 7:06:01 AM Leap Therapeutics And BeiGene Says First Patient Dosed In DisTinGuish Study
7/27/2020 9:21:44 AM BeiGene Says Priority Review Granted To NDA Of Pamiparib In Ovarian Cancer In China
7/17/2020 9:03:02 AM BeiGene Reports Acceptance Of NDA Of Pamiparib In Ovarian Cancer In China
7/1/2020 7:09:49 AM BeiGene Appoints Angus Grant As Chief Business Executive
6/19/2020 12:34:10 AM BeiGene Announces Acceptance Of SNDA For Tislelizumab In Combination With Chemotherapy In China